Cannell Capital - PSYCHEMEDICS CORP ownership

Quarter-by-quarter ownership
Cannell Capital ownership history of PSYCHEMEDICS CORP
ValueSharesWeighting
Q3 2023$296,932
-12.9%
74,7940.0%0.07%
+1.5%
Q2 2023$341,061
-13.1%
74,7940.0%0.07%
-10.5%
Q1 2023$392,668
+7.0%
74,7940.0%0.08%
+2.7%
Q4 2022$366,842
-36.2%
74,794
-16.2%
0.07%
-43.9%
Q3 2022$575,000
+1.6%
89,2110.0%0.13%
+15.8%
Q2 2022$566,000
+4.8%
89,211
+13.9%
0.11%
+39.0%
Q1 2022$540,000
+8.4%
78,306
+10.3%
0.08%
+3.8%
Q4 2021$498,00071,0000.08%
Other shareholders
PSYCHEMEDICS CORP shareholders Q4 2023
NameSharesValueWeighting ↓
Tieton Capital Management, LLC 301,282$4,227,0003.76%
QUANTUM CAPITAL MANAGEMENT 56,179$788,0000.42%
Mill Road Capital Management LLC 14,896$209,0000.27%
Gs Investments, Inc. 15,300$214,659,0000.17%
North Star Investment Management Corp. 84,948$1,192,0000.14%
CRAWFORD INVESTMENT COUNSEL INC 310,870$4,362,0000.13%
RBF Capital, LLC 78,495$1,101,0000.13%
Uniplan Investment Counsel, Inc. 123,339$1,730,0000.11%
DEPRINCE RACE & ZOLLO INC 274,416$3,850,0000.10%
KENNEDY CAPITAL MANAGEMENT LLC 446,074$6,258,0000.07%
View complete list of PSYCHEMEDICS CORP shareholders